ET Healthcare vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Isotachophoresis-Based Sample Preparation for Diagnostics & Research
ET Healthcare develops isotachophoresis (ITP) technology for rapid, automated nucleic acid and biomarker sample preparation in life sciences research and diagnostics; enables faster processing with minimal sample volumes;
About
ET Healthcare is a Menlo Park, California-based life sciences instrumentation company that develops sample preparation technology based on isotachophoresis (ITP) — an electrokinetic technique that concentrates and purifies nucleic acids, proteins, and other biomolecules from complex biological samples without centrifugation or column-based purification steps. ITP uses electric fields to focus and separate analytes by their electrophoretic mobility, enabling very rapid (often sub-10-minute) purification from small sample volumes with minimal hands-on steps.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.